DO CENTRAL ANTIADRENERGIC ACTIONS CONTRIBUTE TO THE ATYPICAL PROPERTIES OF CLOZAPINE
DO CENTRAL ANTIADRENERGIC ACTIONS CONTRIBUTE TO THE ATYPICAL PROPERTIES OF CLOZAPINE
复制标题
DOI：
10.1192/s0007125000296852
复制
发表时间：
1992-05-01
影响因子：
10.5
通讯作者：
COHEN, BM
中科院分区：
文献类型：
--
作者：
BALDESSARINI, RJ;HUSTONLYONS, D;COHEN, BM
Full neuropharmacological understanding of the atypical antipsychotic agent clozapine remains elusive. Antidopaminergic actions of most neuroleptics probably contribute to their antipsychotic benefits, but also to neurological side-effects. Clinical evidence of abnormalities of dopamine (DA) and serotonin (5-HT) in psychotic disorders is inconsistent, but there is substantial metabolic and post-mortem evidence for hyperactivity of noradrenalin (NA). Clozapine is only weakly antidopaminergic but is a potent antagonist at brain alpha-1-adrenergic, 5-HT2-serotonergic, and muscarinic receptors. Its apparent limbic-over-extrapyramidal neurophysiological selectivity can be mimicked by combining a typical neuroleptic with a central alpha-1 antagonist. Clozapine strongly upregulates alpha-1 but not DA, receptor abundance, and may supersensitise alpha-1 but not DA receptors in rat brain. Clozapine also selectively increases activity of NA neurons and metabolic turnover in NA more than DA areas of rat brain, and also increases NA, but not DA or 5-HT, metabolites in human CSF. Potential psychotropic effects of selective central antiadrenergic agents may deserve reconsideration.
